ascopubs.org

Neuropathy, skin rash, and hyperglycemia as predictors of response to enfortumab vedotin in locally advanced and metastatic bladder and upper tract urothelial carcinoma.

Survey-based study of treatment sequencing after first-line (1L) enfortumab vedotin/pembrolizumab (EVP) in the evolving landscape of locally advanced/metastatic (la/m) urothelial cancer (UC). This is ...
ascopubs.org

Management and outcomes of rash, peripheral neuropathy (PN), and hyperglycemia (HG) during first-line (1L) treatment (tx) of locally advanced/metastatic urothelial cancer (la ...

Hematologic response in patients with myelofibrosis treated with pacritinib in real-word clinical settings. No. (%) of pts with any 1L Tx modification by AE and 1L Tx group.
Healthline

What to Know About Chemo Rash

Chemo rash is one of the most common side effects of cancer treatment. These rashes usually aren’t serious, but they can cause pain, itching, and other uncomfortable symptoms. Chemotherapy, also ...